文献速递肝病消化道出血消化内镜

肝硬化急性静脉曲张出血质量指标全面依从性与死亡率降低相关:全国审计

Full adherence to cirrhosis quality indicators is associated with lower mortality in acute variceal bleeding: Nationwide audit.
PubMed 文献 · Hepatology · 2024-02-20

一项新加坡全国性急性静脉曲张出血(AVB)审计的嵌套队列研究纳入989例肝硬化AVB患者,评估5项AVB质量指标(QI)的依从性与结局。全面依从率仅56.5%,倾向匹配队列显示全面依从组早期感染、早期再出血、6周及1年死亡率均显著低于次优依从组(p<0.05)。结论:应将全面依从AVB QI作为肝硬化质量改进目标。

要点

  • 肝硬化AVB患者全面依从5项QI者仅56.5%。
  • 全面依从与6周及1年死亡率、早期感染和再出血降低相关。
  • 无论MELD评分如何,全面依从均与较低6周死亡率相关。

核心结论

  • 肝硬化AVB患者全面依从5项质量指标与6周及1年死亡率降低相关,应作为质量改进目标。

主要发现

  • 全面依从率仅56.5%。
  • 倾向匹配队列中,全面依从组早期感染20.0% vs 26.9%,早期再出血5.2% vs 10.2%,6周死亡率8.2% vs 19.7%,1年死亡率21.3% vs 35.4%(p<0.05)。
  • 无论MELD评分如何,全面依从与较低6周死亡率相关;不依从与较高6周死亡率相关,尽管预测6周死亡率风险较低。
  • 尽管推荐流程指标依从性高,CTP-C患者仍有较高的再出血、6周和1年死亡率风险。

关键数值与推荐

  • 全面依从定义为满足全部5项QI:预防性抗生素、血管活性药物、及时内镜、指数内镜期间内镜下止血、AVB后非选择性β受体阻滞剂。

临床怎么用

  • 临床应致力于全面依从AVB五项质量指标以改善肝硬化AVB患者结局。
  • CTP-C患者即使流程指标依从性高,仍需关注再出血和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Acute variceal bleeding (AVB) is a major complication in patients with cirrhosis. Using a nationwide AVB audit, we performed a nested cohort study to determine whether full adherence to the AVB quality indicator (QI) improves clinical outcomes in patients with cirrhosis and AVB. APPROACH AND RESULTS: We assessed real-world adherence to AVB QI among patients with cirrhosis admitted for AVB in all public hospitals in Singapore between January 2015 and December 2020. Full adherence was considered when all 5 QIs were fulfilled: prophylactic antibiotics, vasoactive agents, timely endoscopy, endoscopic hemostasis during index endoscopy, and nonselective beta-blockers after AVB. We compare 6-week mortality between the full adherence and suboptimal adherence groups using a propensity-matched cohort.A total of 989 patients with AVB were included. Full adherence to all AVB QI was suboptimal (56.5%). Analysis of the propensity-matched cohort with comparable baseline characteristics showed that full adherence was associated with a lower risk of early infection (20.0% vs. 26.9%), early rebleeding (5.2% vs. 10.2%), and mortality at 6 weeks (8.2% vs. 19.7%) and 1 year (21.3% vs. 35.4%) ( p <0.05 for all). While full adherence was associated with a lower 6-week mortality regardless of the MELD score, nonadherence was associated with a higher 6-week mortality despite a lower predicted risk of 6-week mortality. Despite high adherence to the recommended process measures, patients with CTP-C remain at a higher risk of rebleeding, 6-week and 1-year mortality. CONCLUSIONS: Full adherence to the AVB QI should be the target for quality improvement in patients with cirrhosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wong YJ, Teng M, Sim A, et al. Full adherence to cirrhosis quality indicators is associated with lower mortality in acute variceal bleeding: Nationwide audit. Hepatology. 2024. PMID: 38381716. doi:10.1097/HEP.0000000000000793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。